Artificial Intelligence Blogs
05|21|26
Pharma’s AI Influencer Future Depends on One Question: Why Would Anyone Care?
In a new article published on Med Ad News (Pharma Live), Chief Creative Officer Susan Perlbachs explores what recent consumer backlash to AI influencers reveals about the future of influence in healthcare. The takeaway isn’t that audiences reject AI, but that they reject anything that lacks perspective, purpose, or genuine human value.
05|20|26
Google AI Mode & What It Means for Pharma Search
Google’s shift to AI‑generated search is redefining how patients and healthcare professionals discover information. As advertising moves into conversational, intent‑driven experiences, pharma marketers are being pushed to rethink how they show up in moments that increasingly shape decision‑making.
05|15|26
2026 Pharma AI Overviews Report
In the past four years, AI has altered how users and technology discover and engage with information and continues to evolve and reshape the digital landscape. To better understand this transformation, our GEO/SEO team analyzed 10,000 pharmaceutical-specific keywords, uncovering a hidden layer of AI background searches and a rapidly changing landscape where nearly 75% of keywords now trigger AI Overviews and sources shift frequently.
05|11|26
What Adobe Summit 2026 Signals for Pharma Marketing
Adobe Summit 2026 highlighted a major shift in AI, uncovering new implications for how marketing gets done in pharma. Our latest POV from our team that attended this year’s summit explores what this shift means and how pharma marketers can start preparing for what’s next. Readers will gain insight into: Download the POV to learn more.
04|29|26
4 Takeaways from Google Cloud’s NEXT 2026 and What’s on the Horizon for Pharma
What does the next chapter of AI‑driven transformation mean for pharma? Faruk Capan, Chief Innovation Officer, recently penned an article for pharmaphorum distilling four key takeaways from Google Cloud’s NEXT 2026 conference, highlighting how the industry is moving beyond experimentation toward accountability, integration, and trust at scale. From connected systems to stronger AI governance, the piece offers timely perspective on what pharma organizations must do next to stay competitive.
04|22|26
Reimagining Annual Brand Planning With AI
In a recent article for PM360, Chief Strategy Officer John Kenny explores how AI is reshaping the annual brand planning process from a one-time exercise into a more dynamic, insight-driven model that better reflects today’s complex market realities.
04|08|26
The Fourth Hurdle: In the Search for Truth, Will an Algorithm Find Your Drug?
Launch success once depended on approval, access, and adoption, but today, algorithms have become the new gatekeepers. As the patient journey becomes a data journey, this POV, authored by Barry Vucsko, SVP, Strategic Development, examines what it means for marketers when machines decide what evidence rises to the top.
03|17|26
4th Annual Brand Planning Report: Fueling Brand Plan Success Through AI‑Powered Integration
In our fourth annual report, Chief Strategy Officer at EVERSANA INTOUCH, John Kenny, and Senior Partner of EVERSANA MANAGEMENT CONSULTING, Sean Rapson, explore the state of brand planning with input from pharma marketing executives, uncovering persistent gaps in efficiency, consistency, and the ability to harness data effectively.
01|30|26
Mind + Machine: How 2026 Brands Will Win the Future of Pharma Marketing
In our recent webinar, leaders across strategy, creative, technology and omnichannel disciplines explored one essential question: How do 2026 brands win in a rapidly transforming healthcare ecosystem?
12|22|25
DHC Monthly: What Pharma Marketers Should Act On for 2026
The Digital Health Coalition’s December newsletter spotlights year‑end trends and predictions for 2026, featuring insights 18 industry leaders including Susan Perlbachs and Dan Gandor. Read the blog to learn about their key perspectives for 2026.